Innospec Inc. Files 8-K on Financials
Ticker: IOSP · Form: 8-K · Filed: Nov 6, 2024 · CIK: 1054905
Sentiment: neutral
Topics: financial-condition, results-of-operations, regulation-fd
Related Tickers: IOSP
TL;DR
Innospec dropped an 8-K on Nov 5th covering financials and Reg FD stuff. Check it.
AI Summary
On November 5, 2024, Innospec Inc. filed an 8-K report detailing results of operations and financial condition, along with Regulation FD disclosures and financial statements. The filing was made on November 6, 2024, and pertains to the company's performance as of November 5, 2024. Innospec Inc., incorporated in Delaware, is a chemical and allied products company.
Why It Matters
This 8-K filing provides investors with crucial updates on Innospec Inc.'s operational and financial performance, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate or significant risks.
Key Players & Entities
- Innospec Inc. (company) — Registrant
- November 5, 2024 (date) — Date of earliest event reported
- November 6, 2024 (date) — Date of report filing
- Delaware (jurisdiction) — State of incorporation
- 8310 South Valley Highway , Suite 350 Englewood , Colorado , 80112 (address) — Principal executive offices
FAQ
What specific financial information is being disclosed in this 8-K filing?
The 8-K filing indicates disclosure of 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
What is the exact date of the earliest event reported in this filing?
The earliest event reported is dated November 5, 2024.
When was this 8-K report filed with the SEC?
The report was filed on November 6, 2024.
What is Innospec Inc.'s state of incorporation and IRS Employer Identification Number?
Innospec Inc. is incorporated in Delaware and its IRS Employer Identification No. is 98-0181725.
What are the principal executive offices of Innospec Inc.?
The principal executive offices are located at 8310 South Valley Highway, Suite 350, Englewood, Colorado, 80112.
Filing Stats: 484 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-11-06 06:16:27
Key Financial Figures
- $0.79 — tors declared a semi-annual dividend of $0.79 per share on the Company's common stock
Filing Documents
- d902847d8k.htm (8-K) — 26KB
- d902847dex991.htm (EX-99.1) — 162KB
- g902847g1029215230926.jpg (GRAPHIC) — 4KB
- g902847g1029215231036.jpg (GRAPHIC) — 3KB
- 0001193125-24-251643.txt ( ) — 331KB
- iosp-20241105.xsd (EX-101.SCH) — 3KB
- iosp-20241105_lab.xml (EX-101.LAB) — 18KB
- iosp-20241105_pre.xml (EX-101.PRE) — 11KB
- d902847d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. EXHIBIT INDEX Number Description Method of Filing 99.1 Press Release dated November 5, 2024, announcing Innospec Inc.'s financial results for the fiscal quarter ended September 30, 2024 Filed Herewith 104 Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INNOSPEC INC. Date: November 6, 2024 By: /s/ David B. Jones David B. Jones Senior Vice President, General Counsel and Chief Compliance Officer